Kidney Transplantation Without Lifelong Immunosuppression Edges Toward Reality
7 Articles
7 Articles


Kidney Transplantation Without Lifelong Immunosuppression Edges Toward Reality
(MedPage Today) -- Three-fourths of patients avoided long-term immunosuppression after matched kidney transplant procedures involving donor stem cells, a small randomized trial showed. More than 2 years after transplantation, 15 of 20 patients...
Irit and Zavik Stern from Petah Tikva, married for 46 years and managing the city's B'Medrahav band, underwent a rare kidney transplant when an Irish woman donated a kidney to her husband. Chances of a match between the couple: 1 in 100,000


Although immunosuppressive medications are essential for preventing organ transplant rejection, they also carry several drawbacks. They can cause significant side effects, such as headaches and tremors, and increase the risk of infections and cancer. But what if there were a way to prevent organ rejection without resorting to these medications?
Newswise — ROCHESTER, Minnesota — While immunosuppressive medications are essential for preventing organ transplant rejection, they also have several drawbacks. They can cause severe side effects, such as headaches and tremors, and increase the risk of infections and cancer. But what if there were a way to prevent organ rejection without these medications? This goal is what motivates the work of Dr. Mark Stegall, a longtime Mayo Clinic transplan…
SeaStar Medical's QUELIMMUNE Honored with National Kidney Foundation's Corporate Innovator Award
SeaStar Medical’s QUELIMMUNE, a medical device aimed at treating pediatric acute kidney injury (AKI) due to sepsis, has been recognized with the 2025 Corporate Innovator Award by the National Kidney Foundation (NKF). This accolade underscores the device’s innovative approach to addressing a critical unmet need in nephrology, particularly in pediatric care where AKI leads to high mortality rates and long-term health complications. The Corporate I…
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium